← Back to Search

N/A

Almond for Elevated Hemoglobin A1c Concentrations

N/A
Waitlist Available
Led By Richard D Mattes, PhD
Research Sponsored by Purdue University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 4, week 8, week 12. week 16
Awards & highlights

Study Summary

This trial will study whether eating almonds regularly can help control blood sugar in people with elevated HbA1c.

Who is the study for?
This trial is for adults with diabetes or metabolic diseases who have slightly elevated HbA1c levels (between 5.7 and 7.1%), a BMI between 25-35, and no nut allergies. Participants should not be pregnant, smokers, or have recently changed their medication doses.Check my eligibility
What is being tested?
The study is testing if eating almonds regularly can help control blood sugar levels over time in people with higher than normal HbA1c. Participants will either receive almonds or a control treatment to compare the effects on glycemic control.See study design
What are the potential side effects?
Since this trial involves consuming almonds, potential side effects may include digestive discomfort for those not used to high fiber intake. However, serious side effects are unlikely given that almonds are generally safe to eat.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in HbA1c
HbA1c
Secondary outcome measures
Body composition
Body weight
Chronic glycemia
+4 more
Other outcome measures
Compliance - Vitamin E
Compliance - fatty acid profile

Side effects data

From 2012 Phase 4 trial • 200 Patients • NCT01342510
30%
Pain with injection of propofol
100%
80%
60%
40%
20%
0%
Study treatment Arm
Lidocaine/Magnesium
Control
Lidocaine
Magnesium

Trial Design

2Treatment groups
Experimental Treatment
Group I: Control GroupExperimental Treatment1 Intervention
Participants will consume pretzels every day for 16 weeks, but will not be allowed to consume any other nuts or nut products.
Group II: Almond GroupExperimental Treatment1 Intervention
Participants will consume almonds every day for 16 weeks, but will not be allowed to consume any other nuts or nut products.

Find a Location

Who is running the clinical trial?

Purdue UniversityLead Sponsor
224 Previous Clinical Trials
72,680 Total Patients Enrolled
3 Trials studying Diabetes Mellitus
1,430 Patients Enrolled for Diabetes Mellitus
Almond Board of CaliforniaOTHER
33 Previous Clinical Trials
1,987 Total Patients Enrolled
Richard D Mattes, PhDPrincipal InvestigatorPurdue University
16 Previous Clinical Trials
1,294 Total Patients Enrolled

Media Library

Almond (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT05176197 — N/A
Diabetes Mellitus Research Study Groups: Control Group, Almond Group
Diabetes Mellitus Clinical Trial 2023: Almond Highlights & Side Effects. Trial Name: NCT05176197 — N/A
Almond (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05176197 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial currently accept new participants?

"Yes, according to the information located on clinicaltrials.gov this study is actively looking for participants. This scientific experiment was posted online on February 9th 2022 and its latest edit occurred April 18th 2022. It desires 84 individuals from a single medical centre to join their investigation."

Answered by AI

Am I eligible to join this medical study?

"This medical trial seeks 84 qualified individuals, aged 18 to 70 and with glucose intolerance. Eligible applicants must possess the following features: no medications or a stable dosage of medication over 3 months; robust health; an absence of nut allergies; at least 4 meals per day that include one low nutrient density snack; BMI between 25-35 kg/M^2."

Answered by AI

What goals are this clinical experiment attempting to accomplish?

"This medical study's primary endpoint is a Change in HbA1c. Subsidiary metrics include Body weight (kg), Food intake (kcal), and Insulin response to meal tolerance test (mmol/L)."

Answered by AI

Is senior-aged participation permissible in this trial?

"To participate in this trial, individuals must be within the 18 to 70 year old age range. There are 37 trials for minors and 169 separate studies available for seniors above 65 years of age."

Answered by AI

How extensive is the current population participating in this experiment?

"Affirmative. According to clinicaltrials.gov, this medical trial is actively looking for participants after being posted on February 9th 2022 and last updated on April 18th 2022. 84 individuals need to be enrolled from a single location."

Answered by AI
~27 spots leftby Apr 2025